# Can Weight Loss Drugs Help Reduce COVID-19 Deaths? ABC News recently reported that popular weight loss drugs may have the potential to reduce COVID-19 deaths. Here are the key points from the article: – Weight loss medications like lorcaserin, naltrexone-bupropion, and orlistat were found to be associated with decreased death rates among COVID-19 patients. – The study, published in the journal Obesity, analyzed data from over 77,000 patients with COVID-19 and found a significant link between weight loss drugs and lower mortality. – The researchers suggested that these medications might address underlying health conditions like obesity, which can worsen COVID-19 outcomes. – While more research is needed to confirm these findings, experts believe that weight loss medications could potentially play a role in reducing COVID-19 deaths. ### My Hot Take: The potential impact of weight loss drugs on reducing COVID-19 deaths is promising. By addressing obesity and related health issues, these medications may offer a new avenue for improving outcomes among infected individuals. If you’re interested in exploring weight loss options for better health, consider reaching out to Mindful Evolution for guidance and support. Weight Loss Disclaimer: Individual results may vary. We recommend seeking professional medical advice before starting any weight loss program or taking weight loss medications. Our telehealth services are available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact Mindful Evolution today at 954-639-9960 or visit our website.